Cutting Edge: Lectin-Like Transcript 1 Is a Ligand for the CD161 Receptor 1 - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Journal of Immunology Année : 2005

Cutting Edge: Lectin-Like Transcript 1 Is a Ligand for the CD161 Receptor 1

Résumé

Human NK cells and subsets of T cells or NKT cells express the orphan C-type lectin receptor CD161 (NKR-P1A) of unknown function. In contrast to rodents that possess several NKR-P1 genes coding for either activating or inhibitory receptors, the nature of signals delivered by the single human NKR-P1A receptor is still to be clarified. In this article, we show that the lectin-like transcript 1 (LLT1) molecule is a ligand for the CD161 receptor. Engagement of CD161 on NK cells with LLT1 expressed on target cells inhibited NK cell-mediated cytotoxicity and IFN-␥ secretion. Conversely, LLT1/CD161 interaction in the presence of a TCR signal enhanced IFN-␥ production by T cells. These findings identify a novel ligand/receptor pair that differentially regulate NK and T cell functions.
Fichier sous embargo
Fichier sous embargo
Date de visibilité indéterminée

Dates et versions

inserm-03346776 , version 1 (16-09-2021)

Identifiants

Citer

Hatice Aldemir, Virginie Prod'Homme, Marie-Jeanne Dumaurier, Christelle Retiere, Gwenola Poupon, et al.. Cutting Edge: Lectin-Like Transcript 1 Is a Ligand for the CD161 Receptor 1. Journal of Immunology, 2005, 175 (12), pp.7791-5. ⟨10.4049/jimmunol.175.12.7791⟩. ⟨inserm-03346776⟩
14 Consultations
1 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More